objective is to propose a risk algorithm to distinguish between multiple causes of bleeding. Methods: We use the IETA 1 dataset of consecutive women with abnormal bleeding presenting for ultrasound examination in 18 international centres. A multinomial logistic regression model gives the risks of multiple outcome categories based on input predictors chosen in expert discussion. Results: The IETA 1 dataset consists of 2286 women with abnormal bleeding who underwent ultrasound examination (1645 had sonohysterography) and have a histological diagnosis (n=2131) or at least one year of follow-up (n=155). 1416 women were premenopausal (62%) and 870 women were postmenopausal (38%). We distinguished four pathologies that each require a different action (figure B). 972 (43%) had a polyp or myoma; 781 (34%) had a proliferative/secretory changes, hyperplasia without atypia or endometritis; 223 (10%) had atrophy; and 155 (7%) had an endometrial malignancy or atypical hyperplasia. We propose a two-step algorithm, in which risk estimates can be obtained using unenhanced ultrasound, and more precise risk estimates can be obtained by adding sonohysterographic characteristics (figure A).
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Conclusions:
The proposed algorithm has the potential to reduce harms and costs associated with unnecessary invasive procedures. The next step of our research is to validate predictive performance.
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Objectives: To determine the prognostic role of strict qualitative IETA findings at saline contrast sonohysterography (SCSH) to define endometrial lesions in a cohort of women at high risk of cancer because of postmenopausal bleeding (PMB) and thickened endometrium (≥4mm) at transvaginal sonography (TVS). Methods: 157 consecutive patients were prospectively recruited. SCSH was performed by using a 4.7-mm intrauterine catheter. Intracavitary endometrial lesions were defined according to IETA terms and definitions: localised or extended lesion; smooth or irregular outline; non-uniform homogenous (with regular or irregular cystic areas) or heterogeneous echogenicity. Endometrial biopsy by hysteroscopy was performed under general anesthesia. Pathologic report was considered the gold standard. Results: Median age was 61 (IR 56-68) years. Benign and pre-and-malignant lesions were found in 97 and 60 cases, respectively. In these two subsets of patients, median endometrial thickness (IR) was 8 (6-19) and 16 (10-20), respectively. At multivariate analysis, endometrial thickness >10mm and extended lesion were not significantly independently associated to malignancy. We observed an independent significant predictive role for malignancy for irregular (positive LR 19.42, CI 95% 7.37-51.07, negative LR 0.21, CI 95% 0.13-0.35), and heterogeneous lesions (positive LR 2.13, CI 95% 1.70-2.66, negative LR 0.06, CI 95% 0.02-0.24). When these two variables were combined at SCSH, the post-test probability of cancer went up from 38% to 93% if present, whereas down from 38% to 2% if absent. Conclusions: IETA findings on outline and echogenicity at SCSH of endometrial lesions proved to discriminate benign from malignant better than endometrial thickness and lesion's extension, thus permitting to more appropriately assess patient's risk. 
Objectives:
To assess the impact of high body mass index (BMI) on clinical and sonographic gynecological findings among women with postmenopausal bleeding (PMB). Methods: A prospective study of 509 women, 50 years and older, who underwent endometrial assessment by pelvic ultrasound, saline infusion sonohystogram and endometrial sampling. Clinical, sonographic and histological data was compared between obese women, defined as BMI≥30, and those with BMI<30. Estrogenic endometrium was defined as presence of proliferative or estrogen effect histology. Logistic regression was used to correct for confounders. P<0.05 was considered statistically significant. Results: Patients' mean age was 60.3 (8.1) and mean BMI was 33.4 (7.2). Obese women were similar to non-obese women in age, and number of years since menopause, but had significantly lower levels of follicular stimulation hormone (FSH) (30.6 versus 55.3 p=0.01). On ultrasound, women with BMI≥30 had thicker endometrial echo (3.9 versus 3.2mm, p=0.01), larger mean uterine volume (238.8 versus 119.2cc, p<0.0001), higher incidence of fibroids (69% versus 56%, p=0.03) and larger total ovarian volume (7.70 versus 5.61cc, P=0.02). Logistic regression analysis showed that obesity was associated with a significant increase in estrogenic endometrial histology (OR=2.41, 95% CI, p=0.03), and increased ovarian volume (OR=2.14, 95% CI, p=0.01).
Conclusions:
The increase in estrogenic endometrial histology, endometrial thickness, ovarian and uterine volumes and decreased FSH among obese women suggests a high estrogen milieu with end organ effect. Further studies are needed to assess the clinical significance of these findings.
